![1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride)](https://static.cymitquimica.com/products/86/img/MM0020.03.png "Click to enlarge")
1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride)
CAS: 52568-80-6
Ref. 86-MM0020.03
| 25mg | 758.00 € | ||
| 100mg | 1,176.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Product Information
Name:
1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride)
Synonyms:
- Cimetidine Hydrochloride Imp. C (EP)
- Cimetidine Imp. C (EP)
- 1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride
- Cimetidine Hydrochloride Imp. C (EP) as Dihydrochloride
- Cimetidine Amide Dihydrochloride
- Cimetidine Imp. C (EP) as Dihydrochloride
- Ph Eur Cimetidine Impurity C
- SKF-92422-A2
- Cimetidine Hydrochloride Impurity C
- Cimetidine Impurity C as Dihydrochloride
- See more synonyms
- Cimetidine Impurity C
CAS:
Brand:
Mikromol
Long term storage:
Notes:
Chemical properties
Molecular weight:
343.28
Formula:
C10H18N6OSClH
Color/Form:
Neat
InChI:
InChI=1S/C10H18N6OS.2ClH/c1-7-8(15-6-14-7)5-18-4-3-13-10(12-2)16-9(11)17, 2*1H, , /h6H,3-5H2,1-2H3,(H,14,15)(H4,11,12,13,16,17)
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 86-MM0020.03 1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
